Page 6 of 11 — 256 published developments, newest first.
A comprehensive review in Bone Research details bone aging as a multiscale network of molecular, cellular, and microenvironmental decline, providing a system-level blueprint for next-generation therapeutic rejuvenation.
Read analysisA systematic review in Experimental Gerontology indicates that first-generation epigenetic clocks estimate a five-to-seven-year biological age acceleration in people living with HIV, highlighting both the opportunity for advanced clocks to act as clinical biomarkers and the need for longitudinal validation.
Read analysisA newly published literature review suggests that inactivated influenza vaccines may modulate chronic inflammaging by inducing persistent epigenetic remodeling in myeloid cells, potentially conferring broad heterologous protection against age-related diseases.
Read analysisA published review consolidates preclinical and clinical evidence showing that bioavailability-enhanced resveratrol targets SIRT1/AMPK networks to mitigate age-related cognitive decline, suggesting a need for large-scale randomized controlled trials to establish clinical efficacy.
Read analysisResearchers reported that fine dust exposure accelerates telomere and mitochondrial senescence preferentially in endothelial cells rather than smooth muscle cells, a phenotype partially reversed by Astragaloside IV, showing cell-type-specific susceptibility in vascular aging.
Read analysisA longitudinal study of older adults in India demonstrates that transitions to folate deficiency and persistent hyperhomocysteinemia are directly associated with accelerated biological and epigenetic aging over a 4.5-year period.
Read analysisA multicohort cross-sectional study demonstrates that brain-gut crosstalk is associated with brain aging in young and mid-life adults, supporting early-life systemic interventions for cognitive longevity.
Read analysisResearch published in the Journal of Investigative Dermatology reports that the accumulation of immunoglobulin G in aging tissue drives skin inflammation, providing a specific immunological target for therapies addressing age-related skin pathologies.
Read analysisA multi-clock proteomic analysis of Insilico Medicine's Phase 2a clinical data for its idiopathic pulmonary fibrosis candidate, rentosertib, showed a reduction in predicted biological age of up to six years, establishing a clinical blueprint for dual-purpose therapeutics.
Read analysisResearchers have developed a 3D mechanobiological culture platform that models mechanical and age-associated joint inflammaging in human mesenchymal stromal cells, providing a donor-specific screening tool for osteoarthritis therapies.
Read analysisA prospective cohort study of 7,614 adults indicates that frequent and severe infection trajectories are associated with accelerated biological aging and increased mortality, especially in genetically susceptible individuals.
Read analysisA newly published review outlines how posttranslational oxidation of superoxide dismutase 1 (SOD1) drives skin aging, mapping out key research gaps and future directions for antioxidant-targeted dermatological interventions.
Read analysisMinicircle's selection as a finalist in the $101 million XPRIZE Healthspan competition awards the developer $1 million in cash to fund a placebo-controlled human trial of its non-viral combination gene therapy.
Read analysisA newly published perspective in Biogerontology outlines a biological framework showing how prolonged crisis-induced chronic stress accelerates metabolic ageing, cellular senescence, and sarcopenic obesity, emphasizing the need for integrated clinical screening in vulnerable older populations.
Read analysisThe SENESCENCE2030 network has published a consensus roadmap in Nature Aging to establish standardized biomarkers, functional classifications, and regulatory frameworks required for translating senescence research into clinical therapies.
Read analysisA newly published study reports that environmentally relevant concentrations of the biocide DCOIT reduce both lifespan and healthspan in the model organism Caenorhabditis elegans.
Read analysisA clinical trial has been initiated to evaluate the effects of dexmedetomidine on sleep architecture, circadian rhythms, and physiological biomarkers in older adults.
Read analysisA GeroScience study reveals that treating chemotherapy-exposed mice with dasatinib and quercetin partially restores osteogenic gene expression and reduces bone marrow adiposity, demonstrating that molecular and proteomic microenvironmental rescue precedes significant structural bone recovery.
Read analysisA newly published study reports that age-related failures in ubiquitination and mitochondrial proteostasis are associated with compartment-specific mitochondrial alterations in neurons, highlighting potential sub-cellular targets for neurodegenerative therapeutics.
Read analysisA newly published single-cell multi-omics atlas maps human peripheral immune aging at the transcript-isoform and immune-receptor level, uncovering widespread post-transcriptional splicing alterations linked to T-cell senescence and inflammaging.
Read analysisResearchers have developed PathStAR, a computational framework that maps tissue-specific structural aging trajectories from histopathology images, demonstrating that SIRT6 variants are specifically associated with accelerated vascular aging.
Read analysisA newly published scientific review highlights the IL-6/IL-1 signaling axis as the therapeutic pathway with the most robust clinical support for counteracting inflammaging and cellular senescence in age-related myocardial infarction.
Read analysisA prospective cohort study published in The American Journal of the Medical Sciences demonstrates that biological age acceleration is independently associated with an increased risk of mortality in patients with cardiorenal syndrome.
Read analysisAn NHANES cohort study of 16,837 participants demonstrates that biological age acceleration, particularly Phenotypic Age Acceleration, independently predicts all-cause and cardiovascular mortality in early-stage cardio-kidney-metabolic syndrome.
Read analysis